Bio-Gene Technology Ltd
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with Jame… Read more
Bio-Gene Technology Ltd (BGT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.811x
Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has a cash flow conversion efficiency ratio of -0.811x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-946.61K) by net assets (AU$1.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio-Gene Technology Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Bio-Gene Technology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bio-Gene Technology Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Gene Technology Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wedgemount Resources Corp.
OTCQB:WDGRF
|
-0.003x |
|
Arax Holdings Corp
PINK:ARAT
|
-0.040x |
|
Sycal Ventures Bhd
KLSE:9717
|
0.031x |
|
Eniro Group AB
LSE:0YG8
|
0.040x |
|
F5 NETWORKS - Dusseldorf Stock Exchang
DU:FFV
|
0.053x |
|
IPHSF
OTCGREY:IPHSF
|
N/A |
|
China Ouhua Winery Holdings
KLSE:5188
|
-0.077x |
|
Z.M.H Hammerman Ltd
TA:ZMH
|
-0.103x |
Annual Cash Flow Conversion Efficiency for Bio-Gene Technology Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$1.63 Million | AU$-2.54 Million | -1.563x | -58.38% |
| 2024-06-30 | AU$2.79 Million | AU$-2.75 Million | -0.987x | +2.98% |
| 2023-06-30 | AU$3.22 Million | AU$-3.28 Million | -1.017x | -14751.29% |
| 2022-06-30 | AU$6.27 Million | AU$43.52K | 0.007x | +101.61% |
| 2021-06-30 | AU$4.25 Million | AU$-1.83 Million | -0.430x | -56.90% |
| 2020-06-30 | AU$6.00 Million | AU$-1.64 Million | -0.274x | +38.40% |
| 2019-06-30 | AU$4.95 Million | AU$-2.20 Million | -0.445x | -29.44% |
| 2018-06-30 | AU$6.91 Million | AU$-2.37 Million | -0.344x | -327.50% |
| 2017-06-30 | AU$9.07 Million | AU$-729.15K | -0.080x | +90.93% |
| 2016-06-30 | AU$473.35K | AU$-419.35K | -0.886x | -440.17% |
| 2014-06-30 | AU$290.03K | AU$-47.57K | -0.164x | -- |